1. Home
  2. AMTX vs ELTX Comparison

AMTX vs ELTX Comparison

Compare AMTX & ELTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AMTX
  • ELTX
  • Stock Information
  • Founded
  • AMTX 2005
  • ELTX 2011
  • Country
  • AMTX United States
  • ELTX United States
  • Employees
  • AMTX N/A
  • ELTX N/A
  • Industry
  • AMTX Major Chemicals
  • ELTX Biotechnology: Pharmaceutical Preparations
  • Sector
  • AMTX Industrials
  • ELTX Health Care
  • Exchange
  • AMTX Nasdaq
  • ELTX Nasdaq
  • Market Cap
  • AMTX 108.1M
  • ELTX 121.7M
  • IPO Year
  • AMTX N/A
  • ELTX N/A
  • Fundamental
  • Price
  • AMTX $1.49
  • ELTX $4.76
  • Analyst Decision
  • AMTX Strong Buy
  • ELTX Strong Buy
  • Analyst Count
  • AMTX 4
  • ELTX 2
  • Target Price
  • AMTX $14.56
  • ELTX $9.50
  • AVG Volume (30 Days)
  • AMTX 804.0K
  • ELTX 45.3K
  • Earning Date
  • AMTX 05-08-2025
  • ELTX 05-14-2025
  • Dividend Yield
  • AMTX N/A
  • ELTX N/A
  • EPS Growth
  • AMTX N/A
  • ELTX N/A
  • EPS
  • AMTX N/A
  • ELTX N/A
  • Revenue
  • AMTX $267,640,000.00
  • ELTX N/A
  • Revenue This Year
  • AMTX $34.74
  • ELTX N/A
  • Revenue Next Year
  • AMTX $82.85
  • ELTX N/A
  • P/E Ratio
  • AMTX N/A
  • ELTX N/A
  • Revenue Growth
  • AMTX 43.34
  • ELTX N/A
  • 52 Week Low
  • AMTX $1.31
  • ELTX $3.34
  • 52 Week High
  • AMTX $4.73
  • ELTX $11.45
  • Technical
  • Relative Strength Index (RSI)
  • AMTX 40.78
  • ELTX 30.36
  • Support Level
  • AMTX $1.31
  • ELTX $4.61
  • Resistance Level
  • AMTX $1.64
  • ELTX $5.11
  • Average True Range (ATR)
  • AMTX 0.15
  • ELTX 0.69
  • MACD
  • AMTX -0.02
  • ELTX -0.07
  • Stochastic Oscillator
  • AMTX 25.71
  • ELTX 5.56

About AMTX Aemetis Inc. (DE)

Aemetis Inc is an renewable fuel and biochemicals company focused on the production of renewable fuels and chemicals through the acquisition, development and commercialization of technologies that replace traditional petroleum-based products through the conversion of first-generation ethanol and biodiesel plants into advanced biorefineries. It owns and operates an approximately 65 million gallon per year ethanol production facility located in Keyes, California. In addition to low carbon renewable fuel ethanol, the Keyes Plant produces Wet Distillers Grains, Distillers Corn Oil, and Condensed Distillers Solubles, all of which are sold to local dairies and feedlots as animal feed. It operates in the reportable geographic segments of North America and India.

About ELTX Elicio Therapeutics Inc.

Elicio Therapeutics Inc is a clinical-stage biotechnology company pioneering the development of cancer immunotherapies for patients with limited treatment options and poor outcomes. Its proprietary Amphiphile, or AMP, platform delivers investigational immunotherapeutics directly to the brain center of the immune system the lymph nodes. Its focus is the development of cancer immunotherapies against biologically validated but hard-to-drug targets that can be activated through lymph node trafficking. Elicio is engineering lymph node-targeted AMPlifiers, immunomodulators, adjuvants, and vaccines for an array of aggressive cancers. It has developed its cancer vaccine product candidates to target biologically validated tumor mutation drivers using known neoantigens.

Share on Social Networks: